Prelude Capital Management, LLC Opiant Pharmaceuticals, Inc. Transaction History

Prelude Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$6.87 - $8.88 $9,618 - $12,432	-1,400 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$7.48 - $9.54 $501 - $639	-67 Reduced 4.57%	1,400 $10,000
Q1 2020 May 15, 2020	SELL	$9.11 - $14.42 $6,331 - $10,021	-695 Reduced 32.15%	1,467 $14,000
Q4 2019 Feb 14, 2020	BUY	$13.16 - $15.96 $28,451 - $34,505	2,162 New	2,162 $31,000
Q2 2019 Aug 14, 2019	SELL	$10.25 - $13.98 $118,213 - $161,231	-11,533 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$13.02 - $15.94 $164,885 - $201,864	-12,664 Reduced 52.34%	11,533 $151,000
Q4 2018 Feb 14, 2019	BUY	$13.84 - $18.79 $334,886 - $454,661	24,197 New	24,197 $350,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.